Category: Health Innovation

What if CAR T cells, revolutionary cancer fighters normally manufactured in the lab, could be created inside the patient? This quest to simplify CAR T therapy has brought two biotech companies to a similar answer: viral injections. According to research presented at …

A new, CRISPR-powered gene therapy seeks to rewrite the rules of cholesterol care. The treatment promises to obliterate ‘bad’ cholesterol with a single infusion, marking a potential paradigm shift in cardiovascular care. A Gene for Bad Cholesterol The balance between “good” cholesterol …

Cancer and other diseases could be treated by turning certain genes on and off in the immune system. The method used to activate and inactivate these genes is critical to consider. If the technique does not pinpoint the right cells or lingers …

This story on regulatory T cell function and its therapeutic potential falls within a greater series on regenerative medicine. In 1999, I defined regenerative medicine as the collection of interventions that restore to normal function tissues and organs that have been damaged …

Could CAR T Therapy, an innovative treatment for certain blood cancers, cause lymphoma? Reports from clinical trials and data released after product approval suggest that the treatment could trigger the development of cancerous T cells in rare cases. Although the therapy’s benefits …

All medicine—from Tylenol to the latest innovations in cancer care—is a balance of risk and reward. Each person must ask if the anticipated benefits outweigh the potential damage to the body. This is no different for patients who undergo CAR T therapy, …

Before any treatment, each clinician and patient must determine whether the anticipated benefits outweigh the potential toll caused on the body. Study results published in Nature suggest that latent virus reactivation may be a valid point to consider for CAR T and …